Mutations in SEC63 cause autosomal dominant polycystic liver diseaseSonia Dávila, Stefan Somlo|Nature Genetics|2004Cited by 282
ERK1/2-Dependent Vascular Endothelial Growth Factor Signaling Sustains Cyst Growth in Polycystin-2 Defective MiceCarlo Spirlı̀, Mario Strazzabosco, Silvia Lecchi et al.|Gastroenterology|2009Cited by 98
Mammalian Target of Rapamycin Regulates Vascular Endothelial Growth Factor–Dependent Liver Cyst Growth in Polycystin-2–Defective MiceCarlo Spirlı̀, Mario Strazzabosco, S. Okolicsanyi et al.|Hepatology|2009Cited by 95
The Future of Polycystic Kidney Disease Research—As Seen By the 12 Kaplan AwardeesCorinne Antignac, Alan S.L. Yu, James P. Calvet et al.|Journal of the American Society of Nephrology|2015Cited by 42
Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney diseaseChao Zhang, Stefan Somlo|Nature Communications|2024Cited by 22